Wednesday, December 29, 2021

Chemist/lawyer to psychedelic entrepreneur

Via a random Google search, this profile in the ABA Journal of Dr. Andrew Chadeayne, a lawyer and PhD chemist: 

From a desk in the back of his garage in Issaquah, Washington, a suburb of Seattle, Andrew Chadeayne is quietly, steadily spearheading the convergence of science, law and psychedelic drugs.

Chadeayne, who holds a doctorate in chemistry, is also a patent lawyer. His experience includes intellectual property work for pharmaceutical companies and a major freight forwarder. But it was his work for the revolutionary cannabis research company Ebbu that ignited his interest in developing and commercializing the mind-altering properties of much-maligned plants.

In 2018, Ebbu sold in a deal valued north of $330 million, and Chadeayne decided not to stay with the company. Instead, he founded a company called CaaMTech to explore another pharmacological edible: the magic mushroom.

Pretty interesting stuff - read the whole thing.

1 comment:

  1. Charles Lieber gets in the non-science media. Elisabeth Holmes does, too. On the other hand, there are good startups which succeed without the hype or photegenic stock photos from Harvard or Silicon Valley. It might be interesting to learn more about them.

    ReplyDelete

looks like Blogger doesn't work with anonymous comments from Chrome browsers at the moment - works in Microsoft Edge, or from Chrome with a Blogger account - sorry! CJ 3/21/20